5th Floor, Rajapushpa Summit
Nanakramguda Rd, Financial District, Gachibowli
Hyderabad, Telangana - 500008
Europe Proteomics Market is Segmented by Instrumentation Technology, Services and Software, Reagents, Application (Clinical Diagnostics, Drug Discovery, Other Applications), and Geography
2018 - 2026
Proteomics, over the last decade, has gained importance in the field of diagnosis, drug research, and development. It has various applications ranging from identification of proteins to purification and separation of the protein to study the nature and properties. It has vast applications in identifying some protein-related disorders or diseases in the organism. Thus, it is evolving into an important tool in the field of life sciences.
Furthermore, increasing demand for personalized medicine in Europe along with the presence of key market player such as Merck Co KgA expected to boost regional growth. In addition, positive support from the local authorities in Europe along with the initiatives by research organizations to advance the proteomics technologies such as chemo proteomics, spectrometry are expected to further fuel the market growth. For instance, In 2018 a Thermo Fisher Scientific and Denmark-based Symphogen have collaborated to accelerate innovations in biopharmaceutical characterization. Under the collaboration, companies are planned to develop validated, platform workflows for simplified characterization and quality monitoring of complex therapeutic proteins.
Proteomics is the study of protein structure and function. At the cellular level, proteomics deal with the topics, such as which proteins are expressed, when and where they are expressed, what their structures in both active and inactive states are, what roles they play in the life of the cell, and how they interact with other proteins and molecules.
Report scope can be customized per your requirements. Click here.
To understand key trends, Download Sample Report
The European proteomics market is highly competitive and consists of a number of major players. Companies like Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Bruker Corporation, Danaher Corporation, GE Healthcare, Merck KGaA, Promega Corporation, Thermo Fisher Scientific, Inc., and Waters Corporation, among others.
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing R&D Expenditure and Government Funding for Proteomics
4.2.2 Technological Advancements
4.3 Market Restraints
4.3.1 High Cost of Instruments
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 By Type
5.1.1 By Instrumentation Technology
126.96.36.199 Protein Microarrays
188.8.131.52 X-Ray Crystallography
184.108.40.206 Other Instrumentation Technologies
5.1.2 By Services and Software
220.127.116.11 Core Proteomics Services
18.104.22.168 Bioinformatics Software and Services
5.1.3 By Reagents
5.2 By Application
5.2.1 Clinical Diagnostics
5.2.2 Drug Discovery
5.2.3 Other Applications
22.214.171.124 United Kingdom
126.96.36.199 Rest of Europe
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Agilent Technologies, Inc.
6.1.2 Bio-Rad Laboratories, Inc.
6.1.3 Thermo Fisher Scientific, Inc.
6.1.4 GE Healthcare
6.1.5 Danaher Corporation
6.1.6 Waters Corporation
6.1.7 Promega Corporation
6.1.8 Merck KGaA
6.1.9 Bruker Corporation
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments